Korean Journal of Clinical Laboratory Science (대한임상검사과학회지)

Korean Society for Clinical Laboratory Science (대한임상검사과학회)
권호 표지
DOI QR코드

DOI QR Code

The Inhibitory Effects of Cordycepin on Phosphoproteins including PI3K, Akt, and p38

PI3K, Akt, p38을 포함한 인산화단백질에 대한 Cordycepin의 억제효과

  • Kwon, Hyuk-Woo (College of Veterinary Medicine, Kyungpook National University) ;
  • Lee, Dong-Ha (Department of Biomedical Laboratory Science, Korea Nazarene University)
  • 권혁우 (경북대학교 수의학대학) ;
  • 이동하 (나사렛대학교 임상병리학과)
  • Received : 2017.04.07
  • Accepted : 2017.05.01
  • Published : 2017.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

A species of Cordyceps, an ingredient in Chinese traditional medicine well-known for its major component, cordycepin (3'-deoxyadenosine), has been known to have antiplatelet effects; however, its effects on regulation of phosphoprotein have not been fully elucidated. In this study, we investigated how cordycepin regulates the phosphoprotein, including phosphatidylinositol 3-kinase (PI3K)/Akt and p38, to inhibit platelet aggregation, which are concerned with fibrinogen binding to glycoprotein IIb/IIIa (${\alpha}IIb/{\beta}_3$) and granule secretion in platelets. Our finding suggests that cordycepin inhibits collagen-induced platelet aggregation with $261.1{\mu}M$ of $IC_{50}$ and also inhibits fibrinogen binding to ${\alpha}IIb/{\beta}_3$ by a suppression of PI3K/Akt phosphorylation in a dose dependent manner. In addition, cordycepin further showed to inhibit collagen-induced p38 phosphorylation, reducing granule secretion (i.e. ATP- and serotonin-release) and thromboxane $A_2$ ($TXA_2$) production without regulating cyclooxygenase-1 (COX-1) and thromboxane A synthase (TXAS) activities, as well as phospholipase $C-{\gamma}_2$ ($PLC-{\gamma}_2$) phosphorylation. In conclusion, these results demonstrate that cordycepin-mediated antiplatelet effects were due to the inhibition of fibrinogen binding to ${\alpha}IIb/{\beta}_3$ via the suppression of PI3K/Akt phosphorylation and inhibition of granule secretion & $TXA_2$ production by suppressing p38 phosphorylation. These results strongly indicate that cordycepin might have therapeutic or preventive potential for platelet aggregation-mediated disorders, regulating the phosphoprotein, including PI3K/Akt and p38.

진균 속에 속하는 종인 Cordyceps는 중국의 전통약제로서, 그 유효성분인 cordycepin이 혈소판 응집에 관여한다는 보고가 있지만 phosphoprotein 조절에 관련된 연구는 미흡하다. 본 연구에서는, cordycepin이 fibrinogen binding에 관여한다고 알려진 PI3k/Akt와 $TXA_2$ 분비 및 과립방출에 관여한다고 알려진 p38와 같은 phosphoprotein의 인산화를 어떻게 조절하며 혈소판응집을 억제시키는지 규명하고자 하였다. 그 결과, cordycepin가 $261.1{\mu}M$의 $IC_{50}$으로 collagen이 유도한 혈소판 응집을 강력하게 억제하였고, PI3K와 Akt의 인산화를 감소시키며 ${\alpha}IIb/{\beta}_3$에 대한 fibrinogen 결합을 농도의존적으로 억제하였다. 또한, cordycepin은 collagen이 촉진시킨 p38의 인산화를 억제함으로써, 과립방출의 지표인 ATP 과 serotonin의 방출을 억제하였고 COX-1과 TXAS의 활성 및 $PLC-{\gamma}_2$ 인산화에 대한 영향없이 $TXA_2$ 생성량을 감소시켰다. 따라서, cordycepin은 PI3K/Akt, p38와 같은 phosphoprotein의 인산화를 억제함으로써 혈소판 응집억제를 나타내는 항혈전 치료 및 예방약물로서 유용한 가치가 있다고 여겨진다.

Keywords

References

  1. Lee MR, Choi JH, Yang Y, Oh KS, Jeong TS, Lee CH, et al. Attenuation of Atherosclerosis by 3,4-Dihydroxy-Hydrocinnamic Acid in Rabbits by Partial Inhibition of ACAT. Korean J Clin Lab Sci. 2016;48(4):280-286. https://doi.org/10.15324/kjcls.2016.48.4.280
  2. Schwartz SM, Heinmark RL, Majesky MW. Developmental mechanisms underlying pathology of arteries. Physiol Rev. 1990;70(4):1177-1209. https://doi.org/10.1152/physrev.1990.70.4.1177
  3. Payrastre B, Missy K, Trumel C, Bodin S, Plantavid M, Chap H. The integrin alpha IIb/beta 3 in human platelet signal transduction. Biochem Pharmacol. 2000;60(8):1069-1074. https://doi.org/10.1016/S0006-2952(00)00417-2
  4. Phillips DR, Nannizzi-Alaimo L, Prasad KS. Beta3 tyrosine phosphorylation in alphaIIbbeta3 (platelet membrane GP IIb-IIIa) outside-in integrin signaling. Thromb Haemost. 2001;86(1):246-258. https://doi.org/10.1055/s-0037-1616222
  5. Morello F, Perino A, Hirsch E. Phosphoinositide 3-kinase signalling in the vascular system. Cardiovasc Res. 2009;82(2):261-271. https://doi.org/10.1093/cvr/cvn325
  6. Jennings LK. Role of platelets in atherothrombosis. Am J Cardiol. 2009;103(3 Suppl):4-10.
  7. Sabatine MS, Jang IK. The use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease. Am J Med. 2000;109(3):224-237. https://doi.org/10.1016/S0002-9343(00)00474-5
  8. Wonerow P, Obergfell A, Wilde JI, Bobe R, Asazuma N, Brdicka T, et al. Differential role of glycolipid-enriched membrane domains in glycoprotein VI- and integrin-mediated phospholipase Cgamma2 regulation in platelets. Biochem J. 2002;364(3):755-765. https://doi.org/10.1042/bj20020128
  9. Quinton TM, Dean WL. Cyclic AMP-dependent phosphorylation of the inositol-1,4,5-trisphosphate receptor inhibits Ca2+ release from platelet membranes. Biochem Biophys Res Commun. 1992;184(2):893-899. https://doi.org/10.1016/0006-291X(92)90675-B
  10. Nishikawa M, Tanaka T, Hidaka H. $Ca^{2+}$-calmodulin dependent phosphorylation and platelet secretion. Nature. 1980;287(5785):863-865. https://doi.org/10.1038/287863a0
  11. Kaibuchi K, Sano K, Hoshijima M, Takai Y, Nishizuka Y. Phosphatidylinositol turnover in platelet activation; calcium mobilization and protein phosphorylation. Cell Calcium. 1982;3(4-5):323-335. https://doi.org/10.1016/0143-4160(82)90020-3
  12. Hamberg M, Svensson J, Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci U S A. 1975;72(8):2994-2998. https://doi.org/10.1073/pnas.72.8.2994
  13. Flevaris P, Li Z, Zhang G, Zheng Y, Liu J, Du X. Two distinct roles of mitogen-activated protein kinases in platelets and a novel Rac1-MAPK-dependent integrin outside-in retractile signaling pathway. Blood. 2009;113(4):893-901. https://doi.org/10.1182/blood-2008-05-155978
  14. Cunningham KG, Manson W, Spring FS, Hutchinson SA. Cordycepin: A metabolic product from cultures Cordyceps militaris Link. Part I. Isolation and characterization. Nature. 1950;166(4231):949
  15. Cho HJ, Cho JY, Rhee MH, Park HJ. Cordycepin (3'-deoxyadenosine) inhibits human platelet aggregation in a cyclic AMP- and cyclic GMP-dependent manner. Eur J Pharmacol 2007;558(1-3):43-51. https://doi.org/10.1016/j.ejphar.2006.11.073
  16. Lee DH, Kim HH, Lim DH, Kim JL, Park HJ. Effect of Cordycepin-Enriched WIB801C from Cordyceps militaris Suppressing Fibrinogen Binding to Glycoprotein IIb/IIIa. Biomol Ther (Seoul). 2015;23(1):60-70. https://doi.org/10.4062/biomolther.2014.086
  17. Lee DH, Kim HH, Cho HJ, Bae JS, Yu YB, Park HJ. Antiplatelet effects of caffeic acid due to Ca(2+) mobilization inhibition via cAMP-dependent inositol-1, 4, 5-trisphosphate receptor phosphorylation. J Atheroscler Thromb. 2014;21(1):23-37.
  18. Patrono C. Aspirin: new cardiovascular uses for an old drug. Am J Med. 2001;110(1A):62-65. https://doi.org/10.1016/S0002-9343(01)00750-1
  19. Cipollone F, Patrignani P, Greco A, Panara MR, Padovano R, Cuccurullo F, et al. Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. Circulation. 1997;96:1109-1116. https://doi.org/10.1161/01.CIR.96.4.1109
  20. Kwon HW, Shin JH, Cho HJ, Rhee MH, Park HJ. Total saponin from Korean Red Ginseng inhibits binding of adhesive proteins to glycoprotein IIb/IIIa via phosphorylation of VASP (Ser(157)) and dephosphorylation of PI3K and Akt. J Ginseng Res. 2016;40(1):76-85. https://doi.org/10.1016/j.jgr.2015.05.004
  21. Lee DH, Kim YJ, Kim HH, Cho HJ, Ryu JH, Rhee MH, et al. Inhibitory effects of epigallocatechin-3-gallate on microsomal cyclooxygenase-1 activity in platelets. Biomol Ther (Seoul). 2013;21(1):54-59. https://doi.org/10.4062/biomolther.2012.075
  22. Cho HJ, Kang HJ, Kim YJ, Lee DH, Kwon HW, Kim YY, et al. Inhibition of platelet aggregation by chlorogenic acid via cAMP and cGMP-dependent manner. Blood Coagul Fibrinolysis. 2012;23(7):629-635. https://doi.org/10.1097/MBC.0b013e3283570846
  23. Lee DH, Cho HJ, Kim HH, Rhee MH, Ryu JH, Park HJ. Inhibitory effects of total saponin from Korean red ginseng via vasodilator-stimulated phosphoprotein-Ser(157) phosphorylation on thrombin-induced platelet aggregation. J Ginseng Res. 2013;37(2):176-186. https://doi.org/10.5142/jgr.2013.37.176
  24. Chang MC, Wang TM, Yeung SY, Jeng PY, Liao CH, Lin TY, et al. Antiplatelet effect by p-cresol, a uremic and environmental toxicant, is related to inhibition of reactive oxygen species, ERK/p38 signaling and thromboxane A2 production. Atherosclerosis. 2011;219(2):559-565. https://doi.org/10.1016/j.atherosclerosis.2011.09.031

Cited by

  1. 버섯원물과 버섯 추출물 그리고 버섯 유래 화합물을 포함한 식품과 기능성식품 vol.15, pp.4, 2017, https://doi.org/10.14480/jm.2017.15.4.155
  2. Inhibitory Effects of Scopoletin in Collagen-induced Human Platelet Aggregation vol.51, pp.1, 2017, https://doi.org/10.15324/kjcls.2019.51.1.34
  3. Cisplatin의 난소암 세포 증식 억제에 관한 신호 전달 기전 vol.52, pp.1, 2017, https://doi.org/10.15324/kjcls.2020.52.1.62